Key result
MK-801 pretreatment cuts ischemic brain damage volume by an absolute ~17% after arterial occlusion.
Answers are grounded in this paper and cite their sources.
The effects of the glutamate N-methyl-D aspartate (NMDA) receptor antagonist, MK-801, upon ischemic brain damage has been examined in anesthetized cats. Focal cerebral ischemia was produced by permanent occlusion of one middle cerebral artery and the animal were killed 6 h later. The amount of early ischemic damage was assessed in coronal sections at 16 predetermined stereotactic planes. Pretreatment with MK-801 (5 mg/kg, i.v.), 30 min before occlusion of the middle cerebral artery significantly reduced the volume of ischemic damage (from 32.7 +/- 4.0% of the cerebral hemisphere in vehicle-treated cats to 16.2 +/- 4.5% in MK-801-treated cats). NMDA receptor antagonists that penetrate the blood-brain barrier, such as MK-801, merit further study as protective agents against ischemic brain damage.
No takes yet. Share an insight, caveat, or question.
Özyurt et al. (1988) studied Focal cerebral ischemia. MK-801 vs. Vehicle was evaluated on Volume of ischemic damage (% of cerebral hemisphere). Pretreatment with MK-801 reduced the volume of ischemic brain damage from 32.7% to 16.2% of the cerebral hemisphere following middle cerebral artery occlusion in cats.
Synapse has enriched 10 related papers. Consider them for comparative context: